TWiV reviews approvals of the first gene therapy for severe hemophilia A in adults and a monoclonal antibody to prevent RSV respiratory disease in babies and toddlers, and a common allele of HLA that mediates asymptomatic SARS-CoV-2 infection through pre-existing T cell immunity due to previous exposure to common cold coronaviruses.

Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Kathy Spindler, and Brianne Barker

Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

MicrobeTV Discord Server
First gene therapy for hemophilia A approved (FDA)
Luxurna, gene therapy for vision loss (FDA)
Anti-RSV monoclonal antibody approved (FDA)
Trial of single-dose Nirsevimab (NEJM)
Letters read on TWiV 1028
Timestamps by Jolene. Thanks!

Weekly Picks

Dickson – Phoenix hits 110 degrees for the 19th day in a row, setting national record
Brianne – James Webb Telescope One Year Anniversary Photo
Kathy – Drone awards photos
Alan – WHO Film Festival winners
Vincent – Thinking, Fast and Slow by Daniel Kahneman

Listener Picks

David – The Mass Extinction Debates: A Science Communication Odyssey

Intro music is by Ronald Jenkees

Send your virology questions and comments to twiv@microbe.tv

TWiV 1028: Asymptomatic SARS-CoV-2 infection and T cells

This Week in Virology